Botox And Myobloc Should Carry Stricter Warnings Consumer Group Petitions FDA
Jan 29th 2008Drug InformationCosmetic Medicine
Citing deaths linked to the use of the drugs, Public Citizen, an American consumer advocacy group has petitioned the US Food and Drug Administration (FDA) to increase its warnings and directly advise patients and doctors about the dangers of botulinum toxin, available commercially as Botox and Myobloc.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
